Showing results (41-50 of 111) with videos related to
Sort By:
Pageof 12
Cancer Research|November 19, 2004
Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signalsLinhua Zou, Brian Barnett, Hana Safah, et al.Antimicrobial Agents and Chemotherapy|October 10, 2007
Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infectionShuang Wei, Benjamin J Daniel, Michael J Brumlik, et al.International Journal of Biological Sciences|April 1, 2020
PPARγ inhibition boosts efficacy of PD-L1 Checkpoint Blockade Immunotherapy against Murine Melanoma in a sexually dimorphic mannerBogang Wu, Xiujie Sun, Bin Yuan, et al.Oncoimmunology|December 3, 2021
CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturationRyan M Reyes, Chenghao Zhang, Yilun Deng, et al.Aging and Cancer|March 6, 2023
Immune checkpoint expression and relationships to anti-PD-L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young miceMyrna G Garcia, Yilun Deng, Clare Murray, et al.Journal for Immunotherapy of Cancer|January 19, 2021
Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switchBin Yuan, Curtis A Clark, Bogang Wu, et al.Experimental Parasitology|February 23, 2011
Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replicationMichael J Brumlik, Standwell Nkhoma, Mark J Kious, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2004
Peptides identified through phage display direct immunogenic antigen to dendritic cellsTyler J Curiel, Cindy Morris, Michael Brumlik, et al.Aging Cell|March 1, 2012
Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cellsLishi Sun, Vincent J Hurez, Suzanne R Thibodeaux, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trialRobert S Svatek, Xiang Ru Zhao, Edwin E Morales, et al.Pageof 12